119 related articles for article (PubMed ID: 9180162)
1. Prostatic kallikrein hK2, but not prostate-specific antigen (hK3), activates single-chain urokinase-type plasminogen activator.
Frenette G; Tremblay RR; Lazure C; Dube JY
Int J Cancer; 1997 May; 71(5):897-9. PubMed ID: 9180162
[TBL] [Abstract][Full Text] [Related]
2. Prostate-specific antigen activates single-chain urokinase-type plasminogen activator.
Yoshida E; Ohmura S; Sugiki M; Maruyama M; Mihara H
Int J Cancer; 1995 Dec; 63(6):863-5. PubMed ID: 8847146
[TBL] [Abstract][Full Text] [Related]
3. Regulation of single chain urokinase binding, internalization, and degradation by a plasminogen activator inhibitor 1-derived peptide.
Zhang L; Strickland DK; Cines DB; Higazi AA
J Biol Chem; 1997 Oct; 272(43):27053-7. PubMed ID: 9341144
[TBL] [Abstract][Full Text] [Related]
4. Plasminogen-independent initiation of the pro-urokinase activation cascade in vivo. Activation of pro-urokinase by glandular kallikrein (mGK-6) in plasminogen-deficient mice.
List K; Jensen ON; Bugge TH; Lund LR; Ploug M; Danø K; Behrendt N
Biochemistry; 2000 Jan; 39(3):508-15. PubMed ID: 10642175
[TBL] [Abstract][Full Text] [Related]
5. Characterization of hK4 (prostase), a prostate-specific serine protease: activation of the precursor of prostate specific antigen (pro-PSA) and single-chain urokinase-type plasminogen activator and degradation of prostatic acid phosphatase.
Takayama TK; McMullen BA; Nelson PS; Matsumura M; Fujikawa K
Biochemistry; 2001 Dec; 40(50):15341-8. PubMed ID: 11735417
[TBL] [Abstract][Full Text] [Related]
6. Kininogenase activity of prostate-derived human glandular kallikrein (hK2) purified from seminal fluid.
Charlesworth MC; Young CY; Miller VM; Tindall DJ
J Androl; 1999; 20(2):220-9. PubMed ID: 10232657
[TBL] [Abstract][Full Text] [Related]
7. Prostatic human kallikrein 2 inactivates and complexes with plasminogen activator inhibitor-1.
Mikolajczyk SD; Millar LS; Kumar A; Saedi MS
Int J Cancer; 1999 May; 81(3):438-42. PubMed ID: 10209959
[TBL] [Abstract][Full Text] [Related]
8. Structural and functional characterization of mutants of recombinant single-chain urokinase-type plasminogen activator obtained by site-specific mutagenesis of Lys158, Ile159 and Ile160.
Lijnen HR; Nelles L; Van Hoef B; Demarsin E; Collen D
Eur J Biochem; 1988 Nov; 177(3):575-82. PubMed ID: 2973984
[TBL] [Abstract][Full Text] [Related]
9. Enhancement of the enzymatic activity of single-chain urokinase plasminogen activator by soluble urokinase receptor.
Higazi A; Cohen RL; Henkin J; Kniss D; Schwartz BS; Cines DB
J Biol Chem; 1995 Jul; 270(29):17375-80. PubMed ID: 7615542
[TBL] [Abstract][Full Text] [Related]
10. Human kallikrein hK2 has low kininogenase activity while prostate-specific antigen (hK3) has none.
Deperthes D; Marceau F; Frenette G; Lazure C; Tremblay RR; Dubé JY
Biochim Biophys Acta; 1997 Nov; 1343(1):102-6. PubMed ID: 9428664
[TBL] [Abstract][Full Text] [Related]
11. Ala217 is important for the catalytic function and autoactivation of prostate-specific human kallikrein 2.
Mikolajczyk SD; Millar LS; Marker KM; Grauer LS; Goel A; Cass MM; Kumar A; Saedi MS
Eur J Biochem; 1997 Jun; 246(2):440-6. PubMed ID: 9208936
[TBL] [Abstract][Full Text] [Related]
12. A sequence-dependent monoclonal antibody specific for single-chain urokinase.
Charpie JR; Haber E; Matsueda GR
Biochem Biophys Res Commun; 1988 Apr; 152(2):910-5. PubMed ID: 3365258
[TBL] [Abstract][Full Text] [Related]
13. Activation of latent protease function of pro-hK2, but not pro-PSA, involves autoprocessing.
Denmeade SR; Lövgren J; Khan SR; Lilja H; Isaacs JT
Prostate; 2001 Jul; 48(2):122-6. PubMed ID: 11433422
[TBL] [Abstract][Full Text] [Related]
14. Immunohistochemical study suggesting a complementary role of kallikreins hK2 and hK3 (prostate-specific antigen) in the functional analysis of human prostate tumors.
Tremblay RR; Deperthes D; Têtu B; Dubé JY
Am J Pathol; 1997 Feb; 150(2):455-9. PubMed ID: 9033261
[TBL] [Abstract][Full Text] [Related]
15. Characterization of the precursor of prostate-specific antigen. Activation by trypsin and by human glandular kallikrein.
Takayama TK; Fujikawa K; Davie EW
J Biol Chem; 1997 Aug; 272(34):21582-8. PubMed ID: 9261179
[TBL] [Abstract][Full Text] [Related]
16. Interplay of human tissue kallikrein 4 (hK4) with the plasminogen activation system: hK4 regulates the structure and functions of the urokinase-type plasminogen activator receptor (uPAR).
Beaufort N; Debela M; Creutzburg S; Kellermann J; Bode W; Schmitt M; Pidard D; Magdolen V
Biol Chem; 2006 Feb; 387(2):217-22. PubMed ID: 16497155
[TBL] [Abstract][Full Text] [Related]
17. Proteolytic cleavage of urokinase-type plasminogen activator by stromelysin-1 (MMP-3).
Ugwu F; Van Hoef B; Bini A; Collen D; Lijnen HR
Biochemistry; 1998 May; 37(20):7231-6. PubMed ID: 9585535
[TBL] [Abstract][Full Text] [Related]
18. Activation with plasmin of tow-chain urokinase-type plasminogen activator derived from single-chain urokinase-type plasminogen activator by treatment with thrombin.
Lijnen HR; Van Hoef B; Collen D
Eur J Biochem; 1987 Dec; 169(2):359-64. PubMed ID: 2961562
[TBL] [Abstract][Full Text] [Related]
19. Design and evaluation of a thrombin-activable plasminogen activator.
Yang WP; Goldstein J; Procyk R; Matsueda GR; Shaw SY
Biochemistry; 1994 Mar; 33(8):p606-12. PubMed ID: 8117652
[TBL] [Abstract][Full Text] [Related]
20. The mechanism of activation of rabbit plasminogen by urokinase.
Sodetz JM; Castellino FJ
J Biol Chem; 1975 Apr; 250(8):3041-9. PubMed ID: 123529
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]